Guneet Awal
Guneet Awal
Guneet Awal
Nomination By Self
Nominee Name GUNEET AWAL
Nominee Organization SGRD INSTITUTE OF MEDICAL SCIENCES & RESEARCH , AMRITSAR
City AMRITSAR
State Punjab
Mobile no 9988834379
Specialization/Field of work DERMATOLOGY
Date of Birth 7/11/1985
Total Experience in Years 15
Brief Bio in Pursuit of Research Working As Associate Professor in Dermatology in Post Graduate Teaching SGRD Institute of
Medical Sciences & Research, Amritsar.
Member of SIG (Special Interest Group) PIGMENTARY DISEASES IADVL FOR THE YEAR 2023-25
LIFE MEMBER IADVL
Was awarded with Sir Ratan Tata scholarship twice for excellence in academics
Have been awarded the prestigious 25th World Congress of Dermatology,2023 (WCD2023)
scholarship
3.Awal G, Kapoor P. Pediatric Tendinous Xanthomas. Indian Pediatr. 2022 Jul 15;59(7):588.
PMID: 35869883.
2.What according to you is the future The future of dermatology research holds exciting potential, driven by advancements in
road map of research/s undertaken by personalized medicine, therapeutic techniques, and a deeper understanding of dermatological
you* diseases. My research will continue to explore key areas such as vitiligo, intralesional wart
treatment, cutaneous oncology, pediatric dermatology, and cosmetic dermatology, each with a
distinct future trajectory.
Vitiligo Quality of Life and Impact Studies: Future research will focus on the genetic and
immunological mechanisms of vitiligo to develop targeted therapies. Integrating genomic and
proteomic technologies will identify biomarkers for early diagnosis and treatment response,
while expanding our understanding of the psychosocial impact will enhance comprehensive care
strategies addressing both physical and mental health.
Intralesional Warts Using MMR: Future studies will explore the long-term efficacy and safety of
the MMR vaccine for intralesional wart treatment. Research will aim to optimize dosage,
frequency, and combination therapies, improving patient outcomes. Collaborating with
immunologists will uncover mechanisms behind wart regression, leading to novel
immunotherapeutic approaches.
Cosmetology and Dermatology in Pediatric Age Group: Research will develop age-appropriate
cosmetic dermatology treatments for children and adolescents. Focusing on safe and effective
interventions for common pediatric skin conditions, we will consider the unique physiological
and psychological needs of younger patients. Collaborations with pediatricians and child
psychologists will ensure holistic care approaches.
3. Describe the Clinical Utility/ Impact The clinical utility and impact of my dermatology research have transformed patient care,
and Applicability of the Research treatment protocols, and dermatological practice. The following areas highlight the profound
contribution made by you effects of our research:
Vitiligo Quality of Life and Impact Studies: Our research on vitiligo’s quality of life and impact has
provided invaluable insights into the psychosocial challenges faced by patients. This has
informed the development of patient-centered care models integrating psychological support
with medical treatment, improving patient outcomes and overall well-being.
Intralesional Warts Using MMR: The MMR vaccine for intralesional wart treatment has
revolutionized the management of recalcitrant warts. Clinical trials have demonstrated its
efficacy, safety, and cost-effectiveness, leading to widespread adoption. This approach has
reduced the need for invasive procedures, minimized patient discomfort, and improved
treatment success rates.
Cosmetology and Dermatology in Pediatric Age Group: Our research in pediatric dermatology
has ensured safe and effective care for children and adolescents. By tailoring treatments to their
specific needs, we have developed new protocols and educational resources for healthcare
providers and families, enhancing patient care in this vulnerable population.
Cosmetic Dermatology: Our contributions to cosmetic dermatology have set new standards for
4. What are the Public Health The public health implications of my dermatology research extend beyond individual patient
Implication of research/s made by you care, influencing health policies, community health initiatives, and educational programs. The
following areas underscore the societal benefits of our research contributions:
Vitiligo Quality of Life and Impact Studies: Our research on vitiligo has highlighted the need for
comprehensive public health strategies supporting affected individuals. Raising awareness about
the psychosocial impact of vitiligo has advocated for increased mental health services and social
support programs. Public health campaigns informed by our findings have reduced stigma,
promoted acceptance, and improved the quality of life for vitiligo patients.
Intralesional Warts Using MMR: The MMR vaccine for wart treatment has had significant public
health benefits. Providing an effective and accessible treatment option has reduced the
prevalence of recalcitrant warts and associated healthcare costs. Our research has also
emphasized the importance of immunization programs, highlighting vaccines' broader
implications in dermatological care.
Cosmetology and Dermatology in Pediatric Age Group: Our work in pediatric dermatology has
informed public health policies focused on the well-being of children and adolescents.
Advocating for age-appropriate treatments and educational resources has promoted safe
dermatological care for younger populations. Public health programs can utilize our research to
develop guidelines and interventions addressing common pediatric skin conditions.
5. What makes you the best candidate As a passionate and dedicated researcher in dermatology, I have consistently demonstrated
for this award? excellence and innovation in my work, making me a strong candidate for the Young Researcher
Award. My journey in the field is marked by a commitment to advancing dermatological science
through rigorous research, impactful publications, and meaningful contributions to education
and mentorship.
Innovative and Impactful Research: One of the defining features of my research is the innovative
approach I take to solving complex dermatological issues. For example, my work on the use of
the MMR vaccine for intralesional wart treatment introduced a novel, effective method that has
been widely adopted in clinical practice. Additionally, my studies on the quality of life for vitiligo
patients have provided critical insights that have informed more holistic, patient-centered
treatment strategies. These contributions highlight my ability to translate scientific findings into
practical solutions that improve patient care.
2.SCHOLARSHIPS:
Have been awarded the prestigious 25th World Congress of Dermatology,2023 (WCD2023)
scholarship
Presented Poster titled “Assessment of quality of life score in Indian patients with vitiligo and its
correlation with clinical severity scores: A cross sectional study” for electronic Poster (e- Poster)
display at 25th World Congress of Dermatology at Singapore.
3.Was awarded with Sir Ratan Tata scholarship twice for excellence in academics.